Partitioning of substituted phenols in liposomewater , biomembrane-water, and octanol-water systems. Environmental science & technology Volume of distribution in drug design, Journal of Medicinal Chemistry, vol.30, issue.585, pp.260-2705691, 1920. ,
Drug solubility : importance and enhancement techniques, ISRN pharmaceutics, 2012. ,
The henderson-hasselbalch equation : its history and limitations, J. Chem. Educ, vol.80, issue.2, p.146, 2003. ,
Current methodologies used for evaluation of intestinal permeability and absorption 24 Food and Drug Administration (FDA) Draft guidance for industry : Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage foms based on a biopharmaceutics classification system, Journal of pharmacological and toxicological methods, vol.44, issue.1, pp.301-312, 2000. ,
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs, Pharmaceutical Research, vol.63, issue.2, pp.2039-2054, 2009. ,
DOI : 10.4161/cbt.1.4.22
Dissolution modeling : factors affecting the dissolution rates of polydisperse powders, pp.1308-1314, 1993. ,
The rate of solution of solid substances in their own solutions, Journal of the American Chemical Society, vol.19, issue.12, pp.930-934, 1897. ,
General solution for diffusion???controlled dissolution of spherical particles. 1. Theory, Journal of Pharmaceutical Sciences, vol.88, issue.7, pp.731-738, 1999. ,
DOI : 10.1021/js980236p
General solution for diffusion???controlled dissolution of spherical particles. 2. Evaluation of experimental data, Journal of Pharmaceutical Sciences, vol.91, issue.2, pp.534-542, 2002. ,
DOI : 10.1002/jps.10039
Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test, Pharmaceutical Research, vol.19, issue.2, pp.1144-1156, 2006. ,
DOI : 10.1002/cpt1976192170
Transpor approaches to the biopharmaceutical design of oral drug delivery systems : prediction of intestinal absorption, Advanced drug delivery reviews, vol.19, issue.3, pp.359-376, 1996. ,
Compartmental transit and dispersion model analysis of small intestinal transit flow in humans, International Journal of Pharmaceutics, vol.140, issue.1, pp.111-118, 1996. ,
Saturable small intestinal drug absorption in humans : modeling and interpretation of cefatrizine data, European journal of pharmaceutics and biopharmaceutics, vol.45, issue.2, pp.199-203, 1998. ,
Characterization of small intestinal transit time distribution in humans, International journal of pharmaceutics, vol.171, issue.2, pp.157-163, 1998. ,
An integrated model for determining causes of poor oral drug absorption, Pharmaceutical research, vol.16, issue.12, pp.1883-1887, 1999. ,
Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Advanced drug delivery reviews, pp.41-67, 2001. ,
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1 : oral solutions, Journal of pharmaceutical sciences, vol.100, issue.12, pp.5324-5345, 2011. ,
A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats, Pharmaceutical Research, vol.20, issue.11, pp.1766-1771, 2003. ,
DOI : 10.1023/B:PHAM.0000003373.72652.c0
A Physiological Model for the Estimation of the Fraction Dose Absorbed in Humans, Journal of Medicinal Chemistry, vol.47, issue.16, pp.474022-4031, 2004. ,
DOI : 10.1021/jm030999b
Passive Diffusion of Weak Organic Electrolytes across Caco???2 Cell Monolayers: Uncoupling the Contributions of Hydrodynamic, Transcellular, and Paracellular Barriers, Journal of Pharmaceutical Sciences, vol.84, issue.10, pp.1197-1204, 1995. ,
DOI : 10.1002/jps.2600841011
Theoretical effects of molecular dimension and configuration on effective diffusion coefficient of macromolecules in microporous membranes, pp.42-47, 1995. ,
A Priori Prediction of Tissue:Plasma Partition Coefficients of Drugs to Facilitate the Use of Physiologically???Based Pharmacokinetic Models in Drug Discovery, Journal of Pharmaceutical Sciences, vol.89, issue.1, pp.16-35, 2000. ,
DOI : 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E
Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism???Based Prediction of Volume of Distribution, Journal of Pharmaceutical Sciences, vol.91, issue.1, pp.129-156, 2002. ,
DOI : 10.1002/jps.10005
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs, Journal of Pharmaceutical Sciences, vol.90, issue.4, pp.436-447, 2001. ,
DOI : 10.1002/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P
Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination, Journal of pharmaceutical sciences, vol.93, issue.6, pp.1628-1640, 2004. ,
Physiologically Based Pharmacokinetic Modeling 1: Predicting the Tissue Distribution of Moderate-to-Strong Bases, Journal of Pharmaceutical Sciences, vol.94, issue.6, pp.1259-1276, 2005. ,
DOI : 10.1002/jps.20322
Tissue Distribution of Basic Drugs: Accounting for Enantiomeric, Compound and Regional Differences Amongst ??-Blocking Drugs in Rat, Journal of Pharmaceutical Sciences, vol.94, issue.6, pp.1237-1248, 2005. ,
DOI : 10.1002/jps.20323
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions, Journal of Pharmaceutical Sciences, vol.95, issue.6, pp.1238-1257, 2006. ,
DOI : 10.1002/jps.20502
Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes, Pharmaceutical Research, vol.243, issue.Suppl 2, pp.918-933, 2007. ,
DOI : 10.1111/j.1365-2125.1995.tb04557.x
General approach for the calculation of tissue to plasma partition coefficients, 56 MATLAB. version 9, pp.457-467, 2008. ,
DOI : 10.1016/j.tiv.2007.09.010
FDA) Draft guidance : Physiologically based pharmacokinetic analyses ? format and content guidance for industry, 2016. https://www.fda. gov/downloads, 2017. ,
Guidance on priniciples of charactérizing and applying pbpk models in risk assessment http://www.who.int/ipcs Physiologically based pharmacokinetic modeling in drug discovery and development : a pharmaceutical industry perspective, International Programme on Chemical Harmonization Project Whorld Health Organization, pp.97247-262, 2010. ,
Physiologically based pharmacokinetic (pbpk) modeling and simulation approaches : a systematic review of published models, applications and model verification, Drug Metabolism and Disposition, p.115, 2015. ,
A novel physiologically-based mechanistic model for predicting oral drug absorption : the advanced dissolution , absorption, and metabolism (adam) modelc, 2007. ,
The simcyp® population-based adme simulator. Expert opinion on drug metabolism & toxicology, pp.211-223, 2009. ,
DOI : 10.1517/17425250802691074
Population-based mechanistic prediction of oral drug absorption, The AAPS journal, vol.11, issue.2, pp.225-237, 2009. ,
PK-Sim??: a physiologically based pharmacokinetic ???whole-body??? model, BIOSILICO, vol.1, issue.4, pp.121-124, 2003. ,
DOI : 10.1016/S1478-5382(03)02342-4
NCBI GEO: mining millions of expression profiles--database and tools, Nucleic Acids Research, vol.33, issue.Database issue, pp.33-562, 2005. ,
DOI : 10.1093/nar/gki022
NCBI GEO: mining tens of millions of expression profiles--database and tools update, Nucleic Acids Research, vol.35, issue.Database, pp.35-760, 2006. ,
DOI : 10.1093/nar/gkl887
âge : min -max) Volontaires sains masculins, pp.18-45 ,